Stockreport

Immune Pharmaceuticals Provides Update on Plans for Oncology Subsidiary, Cytovia, Inc.

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF ENGLEWOOD CLIFFS, New Jersey, May 07, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) (“Immune” or the “Company”), a biopharmaceutical company deve [Read more]